{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T03:51:49Z","timestamp":1765252309435,"version":"3.37.3"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0233032","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T19:14:36Z","timestamp":1589570076000},"page":"e0233032","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI\u2014Evidence from in vitro and in vivo models"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0744-5929","authenticated-orcid":true,"given":"Eugeni","family":"Entchev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-0724","authenticated-orcid":true,"given":"Ingrid","family":"Jantzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Bocart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Bournique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Luccarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Bouchot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Junien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Broqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"Tallandier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"pone.0233032.ref001","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0006-291X(74)90435-5","article-title":"Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: Deficiency of a N-acetylgalactosamine-4-sulfatase.","volume":"60","author":"JF O'Brien","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"pone.0233032.ref002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0006-291X(74)80001-X","article-title":"Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts.","volume":"59","author":"AL Fluharty","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"pone.0233032.ref003","first-page":"3421","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"EF Neufeld","year":"2001"},{"key":"pone.0233032.ref004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI.","volume":"5","author":"V Valayannopoulos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0233032.ref005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2741\/4490","article-title":"Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment","volume":"22","author":"P Harmatz","year":"2017","journal-title":"Front Biosci (Landmark Ed)."},{"issue":"Suppl 5","key":"pone.0233032.ref006","doi-asserted-by":"crossref","first-page":"v13","DOI":"10.1093\/rheumatology\/ker395","article-title":"Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses. Glycosaminoglycan storage is merely the instigator.","volume":"50","author":"LA Clarke","year":"2011","journal-title":"Rheumatology (Oxford)."},{"key":"pone.0233032.ref007","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.beem.2014.08.010","article-title":"The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders.","volume":"29","author":"LA Clarke","year":"2015","journal-title":"Best practice & Research clinical endocrinology & Metabolism."},{"key":"pone.0233032.ref008","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis. Presentation, diagnosis and management","volume":"34","author":"EA Braunlin","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"pone.0233032.ref009","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2011.06.097","article-title":"Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).","volume":"158","author":"A Golda","year":"2012","journal-title":"Int J Cardiol"},{"key":"pone.0233032.ref010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/clc.4960100612","article-title":"Endocardial fibroelastosis in mucopolysaccharidosis type VI.","volume":"10","author":"LV Fong","year":"1987","journal-title":"Clin Cardiol"},{"key":"pone.0233032.ref011","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.eye.6701921","article-title":"The ocular features of the mucopolysaccharidoses.","volume":"20","author":"JL Ashworth","year":"2006","journal-title":"Eye (Lond)."},{"key":"pone.0233032.ref012","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0002-9394(14)73311-2","article-title":"Glaucoma in the Maroteaux-Lamy syndrome","volume":"108","author":"LB Cantor","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"pone.0233032.ref013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14728214.2016.1123690","article-title":"Emerging drugs for the treatment of mucopolysaccharidoses.","volume":"21","author":"R Giugliani","year":"2016","journal-title":"Expert Opin Emerg Drugs"},{"key":"pone.0233032.ref014","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40265-019-01147-4","article-title":"Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.","volume":"79","author":"K Sawamoto","year":"2019","journal-title":"Drugs"},{"key":"pone.0233032.ref015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).","volume":"144","author":"P Harmatz","year":"2004","journal-title":"J Pediatr"},{"key":"pone.0233032.ref016","first-page":"CD009806","article-title":"Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI","volume":"3","author":"MJ Brunelli","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0233032.ref017","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/OPTH.S78368","article-title":"Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.","volume":"9","author":"CR Fenzl","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"pone.0233032.ref018","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1538-7836.2006.02064.x","article-title":"A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis","volume":"4","author":"JR Toomey","year":"2006","journal-title":"J Thromb Haemost"},{"key":"pone.0233032.ref019","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1016\/S0021-9258(19)41195-2","article-title":"Stimulation of synthesis of free chondroitin sulfate chains by beta-D-xylosides in cultured cells","volume":"250","author":"L Galligani","year":"1975","journal-title":"J Biol Chem"},{"key":"pone.0233032.ref020","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1016\/S0021-9258(17)39958-1","article-title":"Regulation of chondroitin sulfate synthesis. Effect of beta-xylosides on synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein","volume":"252","author":"NB Schwartz","year":"1977","journal-title":"J Biol Chem"},{"key":"pone.0233032.ref021","doi-asserted-by":"crossref","first-page":"19159","DOI":"10.1074\/jbc.271.32.19159","article-title":"Unusual beta-D-xylosides that prime glycosaminoglycans in animal cells","volume":"271","author":"FN Lugemwa","year":"1996","journal-title":"J Biol Chem"},{"key":"pone.0233032.ref022","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1021\/acs.accounts.7b00289","article-title":"Synthetic Xylosides. Probing the Glycosaminoglycan Biosynthetic Machinery for Biomedical Applications","volume":"50","author":"JS Chua","year":"2017","journal-title":"Acc Chem Res"},{"issue":"Pt 2","key":"pone.0233032.ref023","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/jcs.113.2.193","article-title":"Synthesis and sorting of proteoglycans","volume":"113","author":"K Prydz","year":"2000","journal-title":"J Cell Sci"},{"key":"pone.0233032.ref024","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0006-291X(74)90664-0","article-title":"Biosynthesis of chondroitin sulfate: interaction between xylosyltransferase and galactosyltransferase","volume":"56","author":"NB Schwartz","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"pone.0233032.ref025","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1074\/jbc.270.6.2662","article-title":"The effect of the beta-D-xyloside naroparcil on circulating plasma glycosaminoglycans. An explanation for its known antithrombotic activity in the rabbit","volume":"270","author":"PJ Masson","year":"1995","journal-title":"J Biol Chem"},{"key":"pone.0233032.ref026","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/03008207.2011.620190","article-title":"\u03b2-D-xylosides stimulate GAG synthesis in chondrocyte cultures due to elevation of the extracellular GAG domains, accompanied by the depletion of the intra-pericellular GAG pools, with alterations in the GAG profiles","volume":"53","author":"T Weinstein","year":"2012","journal-title":"Connect Tissue Res"},{"key":"pone.0233032.ref027","doi-asserted-by":"crossref","first-page":"28881","DOI":"10.1074\/jbc.M805939200","article-title":"Inhibition of heparan sulfate and chondroitin sulfate proteoglycan biosynthesis","volume":"283","author":"DR Garud","year":"2008","journal-title":"J Biol Chem"},{"key":"pone.0233032.ref028","doi-asserted-by":"crossref","first-page":"e0146499","DOI":"10.1371\/journal.pone.0146499","article-title":"Targeting of Proteoglycan Synthesis Pathway: A New Strategy to Counteract Excessive Matrix Proteoglycan Deposition and Transforming Growth Factor-\u03b21-Induced Fibrotic Phenotype in Lung Fibroblasts.","volume":"11","author":"I Shaukat","year":"2016","journal-title":"PLoS ONE."},{"key":"pone.0233032.ref029","article-title":"A mutation in the Arsb gene; a mouse model that resembles Maroteaux-Lamy syndrome","author":"MM Curtain","year":"2009","journal-title":"MGI Direct Data Submission."},{"key":"pone.0233032.ref030","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/jbmr.3563","article-title":"The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover","volume":"33","author":"S Pohl","year":"2018","journal-title":"J Bone Miner Res"},{"key":"pone.0233032.ref031","first-page":"e1236","article-title":"Dimethylmethylene Blue Assay (DMMB).","volume":"4","author":"VJ Coulson-Thomas","year":"2014","journal-title":"Bio-protocol."},{"key":"pone.0233032.ref032","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(84)90276-9","article-title":"Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody","volume":"38","author":"Z Avnur","year":"1984","journal-title":"Cell"},{"key":"pone.0233032.ref033","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1016\/S0021-9258(17)39872-1","article-title":"Subcellular localization of the synthesis and glycosylation of chondroitin sulfate proteoglycan core protein","volume":"259","author":"M Geetha-Habib","year":"1984","journal-title":"J Biol Chem"},{"key":"pone.0233032.ref034","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005199","article-title":"Golgi glycosylation","volume":"3","author":"P. Stanley","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"pone.0233032.ref035","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1016\/j.bbagen.2013.06.006","article-title":"Biosynthesis and function of chondroitin sulfate","volume":"1830","author":"T Mikami","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"pone.0233032.ref036","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1073\/pnas.93.16.8214","article-title":"Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI","volume":"93","author":"M Evers","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0233032.ref037","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000084085.65972.3F","article-title":"Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI","volume":"54","author":"OF Strauch","year":"2003","journal-title":"Pediatr Res"},{"key":"pone.0233032.ref038","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002239900656","article-title":"Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI","volume":"65","author":"JD Nuttall","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"pone.0233032.ref039","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/030098588902600402","article-title":"Morphology of leukocytes from cats affected with alpha-mannosidosis and mucopolysaccharidosis VI (MPS VI).","volume":"26","author":"J Alroy","year":"1989","journal-title":"Vet Pathol"},{"key":"pone.0233032.ref040","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/jcp.2005.027045","article-title":"Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre","volume":"58","author":"G Anderson","year":"2005","journal-title":"J Clin Pathol"},{"key":"pone.0233032.ref041","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1055\/s-0037-1614604","article-title":"Further studies on the mechanism for the antithrombotic effects of naroparcil, an orally active thioxyloside compound","volume":"81","author":"P Masson","year":"1999","journal-title":"Thromb Haemost"},{"key":"pone.0233032.ref042","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0091270008323751","article-title":"Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin","volume":"48","author":"AL Myers","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"pone.0233032.ref043","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/glycob\/cwh035","article-title":"Tumor attenuation by 2(6-hydroxynaphthyl)-beta-D-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products.","volume":"14","author":"K Mani","year":"2004","journal-title":"Glycobiology"},{"key":"pone.0233032.ref044","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.1074\/jbc.M116.716829","article-title":"Xyloside-primed Chondroitin Sulfate\/Dermatan Sulfate from Breast Carcinoma Cells with a Defined Disaccharide Composition Has Cytotoxic Effects in Vitro","volume":"291","author":"A Persson","year":"2016","journal-title":"J Biol Chem"},{"key":"pone.0233032.ref045","doi-asserted-by":"crossref","first-page":"e0182301","DOI":"10.1371\/journal.pone.0182301","article-title":"A glycan-based approach to therapeutic angiogenesis.","volume":"12","author":"JS Chua","year":"2017","journal-title":"PLoS ONE"},{"issue":"Pt 3","key":"pone.0233032.ref046","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1242\/jcs.108.3.1307","article-title":"Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors","volume":"108","author":"LC Smith-Thomas","year":"1995","journal-title":"J Cell Sci"},{"key":"pone.0233032.ref047","doi-asserted-by":"crossref","first-page":"e25480","DOI":"10.1371\/journal.pone.0025480","article-title":"Exogenous addition of a C-xylopyranoside derivative stimulates keratinocyte dermatan sulfate synthesis and promotes migration.","volume":"6","author":"J Muto","year":"2011","journal-title":"PLoS ONE"},{"key":"pone.0233032.ref048","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13023-014-0135-3","article-title":"A modified liquid chromatography\/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.","volume":"9","author":"C-K Chuang","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0233032.ref049","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2014.09.009","article-title":"A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses","volume":"114","author":"H Zhang","year":"2015","journal-title":"Mol Genet Metab"},{"key":"pone.0233032.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2326409813517663","article-title":"Lysosomal Storage Diseases","volume":"2","author":"J Alroy","year":"2014","journal-title":"Journal of Inborn Errors of Metabolism and Screening"},{"key":"pone.0233032.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2326409814567741","article-title":"Enzyme Replacement Therapy With Elosulfase Alfa Decreases Storage of Glycosaminoglycan in White Blood Cells of Patients With Morquio A Syndrome","volume":"3","author":"G Baldo","year":"2015","journal-title":"Journal of Inborn Errors of Metabolism and Screening"},{"key":"pone.0233032.ref052","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0925-4439(97)00036-7","article-title":"Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models","volume":"1361","author":"DA Brooks","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"pone.0233032.ref053","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1681\/ASN.2013030290","article-title":"Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy","volume":"25","author":"H Debiec","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"pone.0233032.ref054","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI118617","article-title":"Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome","volume":"97","author":"AC Crawley","year":"1996","journal-title":"J Clin Invest"},{"key":"pone.0233032.ref055","article-title":"Enzyme replacement therapy in mice lacking arylsulfatase B targets bone remodeling cells, but not chondrocytes","author":"G Hendrickx","year":"2020","journal-title":"Hum Mol Genet"},{"key":"pone.0233032.ref056","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mgme.2000.3140","article-title":"Enzyme replacement therapy in feline mucopolysaccharidosis I","volume":"72","author":"ED Kakkis","year":"2001","journal-title":"Mol Genet Metab"},{"key":"pone.0233032.ref057","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymgme.2015.11.001","article-title":"Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction","volume":"117","author":"PS Kishnani","year":"2016","journal-title":"Mol Genet Metab"},{"key":"pone.0233032.ref058","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"CM Simonaro","year":"2005","journal-title":"Pediatr Res"},{"key":"pone.0233032.ref059","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2353\/ajpath.2009.090211","article-title":"Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities","volume":"175","author":"S Wilson","year":"2009","journal-title":"Am J Pathol"},{"key":"pone.0233032.ref060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.carpath.2017.01.001","article-title":"Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity","volume":"27","author":"G Baldo","year":"2017","journal-title":"Cardiovasc Pathol"},{"key":"pone.0233032.ref061","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"CM Simonaro","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0233032.ref062","doi-asserted-by":"crossref","first-page":"e22447","DOI":"10.1371\/journal.pone.0022447","article-title":"Anti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis type VI","volume":"6","author":"E Eliyahu","year":"2011","journal-title":"PLoS ONE"},{"key":"pone.0233032.ref063","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/PRM-2010-0117","article-title":"Chondroitin sulfate and growth factor signaling in the skeleton. Possible links to MPS VI","volume":"3","author":"T. Alliston","year":"2010","journal-title":"J Pediatr Rehabil Med"},{"key":"pone.0233032.ref064","doi-asserted-by":"crossref","first-page":"e47933","DOI":"10.1371\/journal.pone.0047933","article-title":"A New C-Xyloside induces modifications of GAG expression, structure and functional properties","volume":"7","author":"E Vassal-Stermann","year":"2012","journal-title":"PLoS ONE"},{"key":"pone.0233032.ref065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/glycob\/cwy049","article-title":"Fine-tuning the structure of glycosaminoglycans in living cells using xylosides","volume":"28","author":"A Persson","year":"2018","journal-title":"Glycobiology"},{"key":"pone.0233032.ref066","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2008.05.001","article-title":"Heparin cofactor II-thrombin complex: a biomarker of MPS disease","volume":"94","author":"DR Randall","year":"2008","journal-title":"Mol Genet Metab"},{"key":"pone.0233032.ref067","article-title":"LC-MS\/MS characterization of xyloside-primed glycosaminoglycans with cytotoxic properties reveals structural diversity and novel glycan modifications","author":"A Persson","year":"2018","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T21:19:52Z","timestamp":1666559992000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233032"}},"subtitle":[],"editor":[{"given":"Sylvie","family":"Fournel-Gigleux","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":67,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0233032","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,5,15]]}}}